BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10916463)

  • 1. [The renin-angiotensin-aldosterone system and chronic renal insufficiency].
    Jovanović DB
    Srp Arh Celok Lek; 2000; 128(1-2):42-9. PubMed ID: 10916463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of renin-angiotensin system on the regulation of renal function and chronic renal insufficiency].
    He M; Lu LM; Yao T
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):188-92. PubMed ID: 15645608
    [No Abstract]   [Full Text] [Related]  

  • 3. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current theories on the hepatorenal syndrome].
    Mysliwiec M; Myśliwiec B
    Przegl Lek; 1983; 40(9):689-92. PubMed ID: 6364259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renin-angiotensin-aldosterone system in chronic renal failure].
    Matsuzaki K; Kinouchi T; Koide K; Shimizu N
    Nihon Rinsho; 1992 Jan; 50 Suppl():573-9. PubMed ID: 1578740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kidney failure and internal secretion--with special reference to the renin-angiotensin-aldosterone system].
    Fukuchi S
    Nihon Jinzo Gakkai Shi; 1972 Jan; 14(1):10-4. PubMed ID: 4344872
    [No Abstract]   [Full Text] [Related]  

  • 8. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endocrine disorders in patients with chronic renal failure].
    Wiecek A; Kokot F
    Postepy Hig Med Dosw; 1989; 43(5-6):423-51. PubMed ID: 2488245
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence and implications of aldosterone breakthrough.
    Bomback AS; Klemmer PJ
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
    Parving HH
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
    [No Abstract]   [Full Text] [Related]  

  • 14. Adaptation of renal function in heart failure.
    Makaritsis KP; Liakopoulos V; Leivaditis K; Eleftheriadis T; Stefanidis I
    Ren Fail; 2006; 28(7):527-35. PubMed ID: 17050233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S
    Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dual blockade of the renin-angiotensin system on thirst in hemodialysis patients.
    Masajtis-Zagajewska A; Nowicki M
    Nephron Clin Pract; 2009; 112(4):c242-7. PubMed ID: 19546583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Gabow PA
    Kidney Int Suppl; 1997 Oct; 61():S71-3. PubMed ID: 9328971
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of hemodynamic regulation in patients with chronic renal insufficiency during hemodialysis].
    Aliev MA; Verbolovich VP; Teplova LL; Lukina OM; Markova GE
    Urol Nefrol (Mosk); 1986; (3):46-50. PubMed ID: 3739098
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertension in chronic renal insufficiency. Study of the involvement of extracellular volume and the renin-angiotensin system].
    Gabbai F; Navarro G; Mendoza V; Herrera Acosta J
    Rev Invest Clin; 1982; 34(4):286-95. PubMed ID: 6763277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.